Filing Details

Accession Number:
0001144204-15-051370
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-21 17:17:38
Reporting Period:
2015-08-19
Filing Date:
2015-08-21
Accepted Time:
2015-08-21 17:17:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563665 Harvard Apparatus Regenerative Technology Inc. HART Surgical & Medical Instruments & Apparatus (3841) 455210462
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449450 Thomas Mcnaughton C/O Hart
84 October Hill Road, Suite 11
Holliston MA 01746
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-19 75,000 $0.62 131,128 No 4 P Direct
Common Stock Acquisiton 2015-08-21 25,000 $0.76 156,128 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $0.59 to $0.66. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 130,023 shares of common stock held by the Reporting Person.
  3. This transaction was executed in multiple trades at prices ranging from $0.72 to $0.78. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 155,023 shares of common stock held by the Reporting Person.